Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 90

Results For "centre"

1047 News Found

Telengana is now home to seven more medical devices companies
News | December 17, 2021

Telengana is now home to seven more medical devices companies

Since its launch, the medical devices park in Sultanpur has received overwhelming response with more than 50 companies lining up to set up their manufacturing or research and development units


Cipla acquires stake in Clean Max Auriga Power
Sustainability | December 16, 2021

Cipla acquires stake in Clean Max Auriga Power

Clean Max Auriga Power is a special purpose vehicle engaged in the business of production, supply and distribution of solar and wind or other renewable energy generation plant


Syngene extends contract with Amgen till 2026
News | December 16, 2021

Syngene extends contract with Amgen till 2026

Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects


NephroPlus raises US $ 24 mn in E round to fund expansion
Startup | December 15, 2021

NephroPlus raises US $ 24 mn in E round to fund expansion

The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)


ICMR Dibrugarh designs kit to detect Omicron variant in two hours
News | December 13, 2021

ICMR Dibrugarh designs kit to detect Omicron variant in two hours

GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model


Cipla aims to improve access to nebulisers in PHCs
Public Health | December 11, 2021

Cipla aims to improve access to nebulisers in PHCs

The company will donate 5000 nebulizers to primary health care centres in rural India


Venus Remedies gets approval under the PLI scheme
News | December 11, 2021

Venus Remedies gets approval under the PLI scheme

Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products


Zydus receives  USFDA  approval for Phase2(b)/3 trial of Saroglitazar
Biotech | December 10, 2021

Zydus receives USFDA approval for Phase2(b)/3 trial of Saroglitazar

Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)


Lupin enters the diagnostics business
Clinical Trials | December 10, 2021

Lupin enters the diagnostics business

Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.


Solve.Care launches Care.Labs to digitise the healthcare experience
Digitisation | December 08, 2021

Solve.Care launches Care.Labs to digitise the healthcare experience

A Care network is a digital health network that connects healthcare stakeholders to deliver streamlined care with the patient at the centre of the experience